{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:12:29Z","timestamp":1793301149247,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Czech Science Foundation project","award":["14-08423S"],"award-info":[{"award-number":["14-08423S"]}]},{"name":"Charles University Grant Agency project","award":["361215"],"award-info":[{"award-number":["361215"]}]},{"name":"Charles University project","award":["SVV 260 291"],"award-info":[{"award-number":["SVV 260 291"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ejmech.2016.11.041","type":"journal-article","created":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T15:14:29Z","timestamp":1479741269000},"page":"369-383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents"],"prefix":"10.1016","volume":"126","author":[{"given":"Galina","family":"Karabanovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"N\u011bme\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Val\u00e1\u0161kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Carazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kl\u00e1ra","family":"Kone\u010dn\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159ina","family":"Stola\u0159\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandr","family":"Hrab\u00e1lek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oto","family":"Pavli\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"P\u00e1vek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate\u0159ina","family":"V\u00e1vrov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u011bra","family":"Klime\u0161ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2016.11.041_bib1","series-title":"Global Tuberculosis Report","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.ejmech.2016.11.041_bib2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJMoa1313865","article-title":"Multidrug-resistant tuberculosis and culture conversion with bedaquiline","volume":"371","author":"Diacon","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2016.11.041_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.tube.2014.04.001","article-title":"Bedaquiline for the treatment of resistant tuberculosis: promises and pitfalls","volume":"94","author":"Kakkar","year":"2014","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejmech.2016.11.041_bib4","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1371\/journal.pmed.0030466","article-title":"OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in\u00a0vitro and in mice","volume":"3","author":"Matsumoto","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejmech.2016.11.041_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4161\/cib.2.3.7926","article-title":"The mechanism of action of PA-824: novel insights from transcriptional profiling","volume":"2","author":"Manjunatha","year":"2009","journal-title":"Commun. Integr. Biol."},{"key":"10.1016\/j.ejmech.2016.11.041_bib6","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1126\/science.1164571","article-title":"PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release","volume":"322","author":"Singh","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2016.11.041_bib7","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1128\/AAC.00106-09","article-title":"Safety, tolerability, and pharmacokinetics of PA-824 in healthy subjects","volume":"53","author":"Ginsberg","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2016.11.041_bib8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/jm2012276","article-title":"Structure-activity relationships for amide-, carbamate-, and urea-linked analogues of the tuberculosis drug (6S)-2-nitro-6-{4-(trifluoromethoxy)benzyl oxy}-6,7-dihydro-5H-imidazo 2,1-b 1,3 oxazine (PA-824)","volume":"55","author":"Blaser","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.11.041_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1128\/AAC.37.2.183","article-title":"Invitro and invivo activities of the nitroimidazole Cgi-17341 against Mycobacterium tuberculosis","volume":"37","author":"Ashtekar","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2016.11.041_bib10","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.4155\/fmc.11.90","article-title":"Nitroimidazoles for the treatment of TB: past, present and future","volume":"3","author":"Mukherjee","year":"2011","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2016.11.041_bib11","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.1171583","article-title":"Benzothiazinones kill Mycobacterium tuberculosis by blocking Arabinan synthesis","volume":"324","author":"Makarov","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2016.11.041_bib12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/emmm.201303575","article-title":"Towards a new combination therapy for tuberculosis with next generation benzothiazinones","volume":"6","author":"Makarov","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejmech.2016.11.041_bib13","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1021\/ja211042r","article-title":"Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-beta-d-ribofuranose 2\u2032-oxidase DprE1","volume":"134","author":"Trefzer","year":"2012","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2016.11.041_bib14","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.bmcl.2013.06.069","article-title":"Synthesis and structure-activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents","volume":"23","author":"Gao","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.11.041_bib15","doi-asserted-by":"crossref","first-page":"e1000645","DOI":"10.1371\/journal.ppat.1000645","article-title":"High content screening identifies decaprenyl-phosphoribose 2\u2032 epimerase as a target for intracellular antimycobacterial inhibitors","volume":"5","author":"Christophe","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2016.11.041_bib16","series-title":"Anti-infective Compounds","author":"Priscille","year":"2011"},{"key":"10.1016\/j.ejmech.2016.11.041_bib17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tube.2010.09.001","article-title":"Leads for antitubercular compounds from kinase inhibitor library screens","volume":"90","author":"Magnet","year":"2010","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejmech.2016.11.041_bib18","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1021\/cb300151m","article-title":"Identification of novel inhibitors of M.\u00a0tuberculosis growth using whole cell based high-throughput screening","volume":"7","author":"Stanley","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2016.11.041_bib19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ejmech.2014.05.069","article-title":"1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: a new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant Mycobacteria","volume":"82","author":"Karabanovich","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.11.041_bib20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1039\/C4MD00301B","article-title":"Tetrazole regioisomers in the development of nitro group-containing antitubercular agents","volume":"6","author":"Karabanovich","year":"2015","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2016.11.041_bib21","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1021\/acs.jmedchem.5b00608","article-title":"Development of 3,5-dinitrobenzylsulfanyl-1,3,4-oxadiazoles and thiadiazoles as selective antitubercular agents active against replicating and nonreplicating Mycobacterium tuberculosis","volume":"59","author":"Karabanovich","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.11.041_bib22","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1002\/ejoc.201501056","article-title":"Synthesis and properties of energetic 1,2,4-oxadiazoles","author":"Wang","year":"2015","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2016.11.041_bib23","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.bmc.2016.03.011","article-title":"Rational design, synthesis and biological evaluation of 1,3,4-oxadiazole pyrimidine derivatives as novel pyruvate dehydrogenase complex E1 inhibitors","volume":"24","author":"He","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.11.041_bib24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/10020475","article-title":"5-Furan-2yl[1,3,4]oxadiazole-2-thiol, 5-furan-2yl-4H [1,2,4] triazole-3-thiol and their thiol-thione tautomerism","volume":"10","author":"Kopar\u0131r","year":"2005","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2016.11.041_bib25","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1016\/j.bmc.2006.01.062","article-title":"Tricyclic pharmacophore-based molecules as novel integrin alphavbeta3 antagonists. Part IV: Preliminary control of alphavbeta3 selectivity by meta-oriented substitution","volume":"14","author":"Kubota","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.11.041_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/jm00296a033","article-title":"\u03b1,\u03b1,\u03b1-Trifluorotoluic acid (5-nitrofurfurylidene)hydrazides","volume":"13","author":"Welch","year":"1970","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416309783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416309783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T05:38:33Z","timestamp":1556343513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523416309783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":26,"alternative-id":["S0223523416309783"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.11.041","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.11.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}